Kerry Strong Russell's most recent trade in Terns Pharmaceuticals Inc was a trade of 240,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 1, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Terns Pharmaceuticals Inc | Kerry Strong Russell | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) |